Segment Information

9 Months Ended

Mar. 31, 2016

Segment Reporting [Abstract]

Segment Information

(9) Segment Information

The Company's business is organized along product lines into three principal segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals.

Human Health - includes finished dosage form generic drugs and nutritional products.

Pharmaceutical Ingredients – includes pharmaceutical intermediates and active pharmaceutical ingredients (“APIs”).

Performance Chemicals - The Performance Chemicals segment is made up of two product groups: Specialty Chemicals and Agricultural Protection Products. Specialty Chemicals include a variety of chemicals used in the manufacture of plastics, surface coatings, cosmetics and personal care, textiles, fuels and lubricants, perform to their designed capabilities. Dye and pigment intermediates are used in the color-producing industries such as textiles, inks, paper, and coatings. Organic intermediates are used in the production of agrochemicals.

Agricultural Protection Products include herbicides, fungicides and insecticides that control weed growth as well as control the spread of insects and other microorganisms that can severely damage plant growth.

The Company's chief operating decision maker evaluates performance of the segments based on net sales, gross profit and income before income taxes. Unallocated corporate amounts are deemed by the Company as administrative, oversight costs, not managed by the segment managers. The Company does not allocate assets by segment because the chief operating decision maker does not review the assets by segment to assess the segments' performance, as the assets are managed on an entity-wide basis. During all periods presented, our chief operating decision maker has been the Chief Executive Officer of the Company. In accordance with GAAP, the Company has aggregated certain operating segments into reportable segments because they have similar economic characteristics, and the operating segments are similar in all of the following areas: (a) the nature of the products and services; (b) the nature of the production processes; (c) the type or class of customer for their products and services; (d) the methods used to distribute their products or provide their services; and (e) the nature of the regulatory environment.

Nine Months Ended March 31, 2016 and 2015:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated  Corporate			Consolidated Totals
2016
Net sales	$	175,306	$	118,496	$	129,298	$	-		$	423,100
Gross profit		61,172		20,870		26,696		-			108,738
Income (loss) before income taxes		29,927		8,389		13,776		(8,472	)		43,620
2015
Net sales	$	160,808	$	111,104	$	128,452	$	-		$	400,364
Gross profit		50,829		19,750		23,689		-			94,268
Income (loss) before income taxes		21,096		5,393		9,925		(4,658	)		31,756

Three Months Ended March 31, 2016 and 2015:

	Human Health		Pharmaceutical Ingredients		Performance Chemicals		Unallocated  Corporate			Consolidated Totals
2016
Net sales	$	58,780	$	45,841	$	53,305	$	-		$	157,926
Gross profit		19,125		8,648		10,516		-			38,289
Income (loss) before income taxes		8,630		4,608		6,972		(4,666	)		15,544
2015
Net sales	$	56,305	$	40,548	$	48,943	$	-		$	145,796
Gross profit		19,957		6,674		9,967		-			36,598
Income (loss) before income taxes		8,667		1,533		5,105		(1,679	)		13,626